(Q28216514)

1

0 references

Anne Gompel

2

0 references

William Rostène

3

0 references

Patricia Forgez

Biochemical and Biophysical Research Communications

4

0 references

language of work or name

English

0 references

publication date

12 July 2002

0 references

published in

0 references

volume

295

0 references

issue

2

0 references

page(s)

482-8

0 references

cites work

Neurotensin receptors: binding properties, transduction pathways, and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Structure and functional expression of the cloned rat neurotensin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin stimulates growth of colonic mucosa in young and aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin regulates growth of human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Apoptosis. Its significance in cancer and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

p53-dependent apoptosis pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin Receptor Down-Regulation Induced by Dexamethasone and Forskolin in Rat Hypothalamic Cultures is Mediated by Endogenous Neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Autocrine and paracrine signaling through neuropeptide receptors in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin expression and release in human colon cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

A multihormonal tumor of the pancreas producing neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Src-mediated activation of the human neurotensin/neuromedin N promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

The neurotensin gene is a downstream target for Ras activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin and neuroendocrine regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Posttranslational processing of the neurotensin/neuromedin-N precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9

Quantitative RT-PCR: limits and accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900703-9